The global Porcine Vaccines Market to Show Major Growth Accelerated by Rising Demand and Adoption of Advanced Vaccines


 Porcine vaccines are the biological preparations used for immunizing pigs against various infectious diseases such as foot and mouth disease, classical swine fever, porcine parvovirus, and porcine reproductive and respiratory syndrome. Porcine vaccines help prevent huge economic losses incurred due to morbidity and mortality in pigs from infectious diseases. The global Porcine Vaccines Market is estimated to be valued at US$ 2.4 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The rising demand and adoption of advanced porcine vaccines is driving the growth of the global porcine vaccines market. There has been a significant rise in adoption of subunit and recombinant vaccines globally as they induce stronger immunity and have fewer side effects as compared to traditional modified live and inactivated vaccines. Subunit and recombinant vaccines account for over 30% share of the global porcine vaccines market currently. Their demand is expected to grow at a faster rate over the forecast period owing to various advantages. Advancements in vaccine technologies such as development of thermostable vaccines not requiring refrigeration and voice-based smart tagging are also fueling market growth. Such innovative vaccines ensure easy transport and administration, and real-time tracking of vaccination of individual pigs.
Segment Analysis
The global porcine vaccines market is dominated by the live attenuated vaccines segment owing to its ability to induce a long lasting immunity against diseases such as PRRS, FMD, and PED. These vaccines provide lifelong protection to pigs against major infectious diseases and help avoid recurrent outbreaks.

Key Takeaways
The global porcine vaccines market is expected to witness high growth during the forecast period of 2023-2030.

Regional analysis
The Asia Pacific region currently dominates the global porcine vaccines market and is expected to grow at the fastest rate during the forecast period. This can be attributed to the growing pork meat consumption and increasing pork production in China and other Asian countries.

Key players
Key players operating in the porcine vaccines market are Boehringer Ingelheim International GmbH. (Germany), FORMOSA BIOMEDICAL INC. (Taiwan), Zoetis (U.S.), Dechra Pharmaceuticals PLC (U.K.), Hester Biosciences Limited. (India), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Elanco (U.S.), Phibro Animal Health Corporation (U.S.), HIPRA, S.A (Spain), Bimeda, Inc (Ireland), Ceva (France), ARKO Laboratories (U.S.).

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more